Delivery Order SPE2DB22D3301-SPE2DB25FY3TT

Award Date 4/23/25
Potential Completion Date 4/24/25
Potential Value $3.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Emgality 120 mg/ml pens, a medication used for the treatment of migraines. The contract has a ceiling value of $1,124.81 and runs through February 16, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Emgality 120 mg/ml Pen Ml, a medication used to treat migraines. The contract has a firm fixed price of $1,729.00 and a period of performance through April 29, 2025. This order is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Emgality 120 mg/ml pens, a medication used to treat migraine. The contract has a firm fixed price and a ceiling value of $2,031.01. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Emgality 120 mg/ml pen injectors, a medication used to treat migraines. The contract has a ceiling value of $8,299.20 and a period of performance ending on June 26, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,548.00, is for the delivery of Emgality 120 mg/mL pens, a medication used to treat migraines. The contract is a firm fixed-price delivery order with an ultimate completion date of April 29, 2025. The award is not associated with a set-aside program, indicating open competition....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the pharmaceutical product Emgality 120 mg/ml pen, a medication used to treat migraine. The contract has a firm fixed price and a ceiling value of $2,074.80, with a period of performance through April 28, 2025. The contract is not set aside and was competitively awarded....
This is a $2,675.40 firm-fixed-price delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of Emgality 120 mg/mL pens, a medication used to treat migraines. The contract is not set aside and represents an open competition award. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Emgality 120 mg/ml Penml, a medication used to treat migraine. The award has a ceiling value of $1,383.20 and a period of performance through March 31, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,037.51 firm-fixed-price contract is for the delivery of Emgality 120 mg/ml pens, a specialty medication used to treat migraines. The award was not set aside for any specific business category. The contract is a delivery order under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the supply of the medication Emgality 120 mg/ml, a treatment for migraine. The total ceiling value of the contract is $3,342.75 and it has a period of performance through April 4, 2024. The contract is a firm fixed price delivery order with no set-aside designation. Amerisourcebergen...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FY3TT
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Emgality 120 mg/ml pens, a medication used to treat migraines. The contract has a ceiling value of $3,495.51 and a performance period ending on April 24, 2025. It is a firm-fixed-price contract, indicating a set price for the goods. This contract is not designated as a set-aside, meaning it was open to full and open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order contract is likely part of that broader IDC, allowing the government to fulfill its pharmaceutical and medical supply needs through a trusted vendor.

Generated 7/23/25, 9:54 AM